Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study
about
sameAs
Acculturation and cardiovascular disease risk in midlife immigrant women from the former Soviet Union.Long term hormone therapy for perimenopausal and postmenopausal womenLong term hormone therapy for perimenopausal and postmenopausal womenLong term hormone therapy for perimenopausal and postmenopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Long-term hormone therapy for perimenopausal and postmenopausal women.Treatment intensification and risk factor control: toward more clinically relevant quality measures.The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul studyQuality of ambulatory care for women and men in the Veterans Affairs Health Care System.Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes.Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.Stable ischemic heart disease in women: current perspectives.Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study.Do gene-environment interactions influence fasting plasma lipids? A study of twins.Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study.
P2860
Q23910094-D0D4B860-87C4-4D5D-AEEF-C76355ADBE2BQ24201974-0D2B7B3D-FA79-4B9A-9851-EE20D4AC5779Q24241279-B9559D29-CD61-495B-A598-81D8A8EA4AFDQ24246577-1314DA72-4515-4644-B93F-AF282B833BF8Q24658109-C52FADF7-DF06-4B35-BCA1-1A30AD486B99Q30238978-B95B9F5B-144C-4533-A4A6-792CADA03C65Q33988413-6AEB211C-FACD-476E-A9B9-7FB9056FAD76Q34022484-E3B50CCE-2A42-4DF7-AC84-12C63FE4F85CQ34308313-5719DC6E-33EF-4B46-9798-70FED92F273FQ34723775-A85B7F2D-B8C4-4AF8-B56A-ED31E2D4497BQ36088805-B979B322-480E-4ABC-B10F-F52E94EE277FQ36455014-D9DF6864-BB41-4EFF-9360-6D78F57062A4Q36572804-3BE50F51-D297-435E-9C31-74ADAA0E42DEQ42370573-08C52C79-3D81-4354-A443-72716513AE85Q44789969-8A7051FF-A3DB-4BCB-8696-7DB34E9FA512Q45067414-5DFDE223-7002-4C15-96AF-8256E98D3CDBQ46714065-A37DE65E-6895-40AE-A7E0-B12580BA4171Q47168348-C354B0B0-9F4D-48F6-993E-CA53354392F8
P2860
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Risk factors and secondary pre ...... en/progestin Replacement Study
@ast
Risk factors and secondary pre ...... en/progestin Replacement Study
@en
Risk factors and secondary pre ...... en/progestin Replacement Study
@nl
type
label
Risk factors and secondary pre ...... en/progestin Replacement Study
@ast
Risk factors and secondary pre ...... en/progestin Replacement Study
@en
Risk factors and secondary pre ...... en/progestin Replacement Study
@nl
prefLabel
Risk factors and secondary pre ...... en/progestin Replacement Study
@ast
Risk factors and secondary pre ...... en/progestin Replacement Study
@en
Risk factors and secondary pre ...... en/progestin Replacement Study
@nl
P2093
P50
P1476
Risk factors and secondary pre ...... en/progestin Replacement Study
@en
P2093
Christine C Ireland
Curt D Furberg
Paul D Varosy
Roger Blumenthal
Stephen Hulley
Steven S Khan
P356
10.7326/0003-4819-138-2-200301210-00007
P407
P577
2003-01-21T00:00:00Z